Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Events
  4. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Life Sciences Solutions
  • Healthcare Solutions
  • Medical Device and Diagnostic
  • U.S. Government
Life Sciences Solutions

Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.

Learn More
Life Sciences Solutions
Healthcare Solutions

Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.

Learn More
Healthcare Solutions
Medical Device and Diagnostic Solutions

Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.

Learn More
Medical Device and Diagnostic Solutions
U.S. Government Solutions

For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.

Learn More
U.S. Government Solutions
MAIN/Insights
Insights/
U.S. PROGRESS POINT

A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.

LEARN MORE
U.S. BLOGS

Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!

LEARN MORE

U.S. INSIGHTS LIBRARY

"Browse our library of insights and thought leadership.

LEARN MORE
MAIN/Events
Events/
ON-DEMAND WEBINARS

Visit our library of on-demand webinars.

LEARN MORE
UPCOMING EVENTS & WEBINARS

View our upcoming events and webinars.

LEARN MORE

FEATURED WEBINAR

"Top Issues for Pharma to Watch in 2022 and 2023

WATCH NOW
MAIN/Contact Us
Contact Us/
WHITE PAPER
The 340B Drug Discount Program Exceeds $100B in 2022
Apr 14, 2023
To download files, please accept Functional Cookies. These cookies provide enhanced functionality for a better user experience.

This article is the latest in IQVIA's series of yearly reports on the size and growth of the 340B drug discount program. In 2022, 340B sales exceeded $100B in WAC dollars for the first time despite contract pharmacy restrictions imposed by manufacturers. Looking forward, 340B growth is likely to be influenced by continued developments in contract pharmacy restrictions and related court cases, the impact of the Inflation Reduction Act, recent changes in pricing strategies in the insulin market, and the possibility of expansion of the 340B patient definition. Download this white paper to learn more.

You may also be interested in

Publication
Patient Support Services and Market Access Quarterly Advisor - Q2 2023
White Paper
Are Discounts in the 340B Drug Discount Program Being Shared with Patients at Contract Pharmacies?
White Paper
Can 340B Modifiers Avoid Duplicate Discounts in the IRA?
White Paper
Journey into the Whirlwind
Fact Sheet
Can 340B Modifiers Avoid Duplicate Discounts in the IRA?
White Paper
A New Margin Era for the Pharmaceutical Industry
Prev
Next

Related solutions

Market Access

Gain high value access and increase the profitability of your brands

Contact Us